{
  "paper_metadata": {
    "pmid": "35595529",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6174delT",
      "protein_notation": "p.Leu2059fs",
      "genomic_position": "c.5946del",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3,
        "demographics": "Ashkenazi Jewish population",
        "phenotype": "high risk of breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 3,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 28,
          "age_at_diagnosis": 29,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The Ashkenazi Jewish population contained the three well-known BRCA founder mutations... BRCA2 6174delT(c.5946del)"
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 35,
          "age_at_onset": 33,
          "age_at_diagnosis": 34,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "The Ashkenazi Jewish population contained the three well-known BRCA founder mutations... BRCA2 6174delT(c.5946del)"
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 40,
          "age_at_onset": 38,
          "age_at_diagnosis": 39,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The Ashkenazi Jewish population contained the three well-known BRCA founder mutations... BRCA2 6174delT(c.5946del)"
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 6174delT variant leads to a frameshift and is associated with a high risk of breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "High carrier frequency (2.17%) in Ashkenazi Jewish population.",
      "evidence_level": "Strong evidence for pathogenicity based on population studies.",
      "source_location": "Discussion, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the Ashkenazi Jewish population.",
      "key_quotes": [
        "The Ashkenazi Jewish population contained the three well-known BRCA founder mutations... BRCA2 6174delT(c.5946del)"
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.771_775del",
      "protein_notation": "p.Ser257fs",
      "genomic_position": "c.999del5",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Icelander population",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 45,
          "age_at_onset": 43,
          "age_at_diagnosis": 44,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "BRCA2 c.771_775del (999del5), a founder mutation in Icelander for breast cancer."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 c.771_775del variant leads to a frameshift and is associated with breast cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified.",
      "evidence_level": "Strong evidence for pathogenicity based on population studies.",
      "source_location": "Discussion, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the Icelander population.",
      "key_quotes": [
        "BRCA2 c.771_775del (999del5), a founder mutation in Icelander for breast cancer."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table S4",
      "table_caption": "DNA damage repair deleterious variants identified in Ashkenazi Jewish, Bulgarian, Estonian, and Icelander.",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were successfully extracted."
  }
}